Thymosin alpha-1 activated peritoneal macrophages to become tumoricidal, increasing their production of reactive oxygen species and NO for direct cancer cell killing — additional evidence for macrophage-mediated antitumor immunity.
Key findingThymosin alpha-1 activated peritoneal macrophages to tumoricidal phenotype with increased reactive oxygen species and nitric oxide production, enablin
What the researchers found
Thymosin alpha-1 activated peritoneal macrophages to tumoricidal phenotype with increased reactive oxygen species and nitric oxide production, enabling direct tumor cell killing — confirming thymosin alpha-1's macrophage activation as a consistent antitumor mechanism.
Why it matters
Relevant for thymosin-alpha-1, cancer, immune-function.
How the study worked
animal-study study on thymosin-alpha-1, cancer.
What this study cannot tell us
See abstract.
How to read the evidence
preliminary evidence.
When this study was published
Published in 2005.
The bigger picture
Advances peptide/biomarker research.
Questions still open
- Further research needed.
- Clinical translation to evaluate.
Common questions
What was studied?
What was found?
Read the original research
Antitumor activation of peritoneal macrophages by thymosin alpha-1.
Cancer investigation, 23(4), 316-22
Citation
Shrivastava, Pratima; Singh, Sukh Mahendra; Singh, Nisha. (2005). Antitumor activation of peritoneal macrophages by thymosin alpha-1.. Cancer investigation, 23(4), 316-22.